Blackstone in Discussions to Acquire Precision Engineering Company Interplex for at Least $1 Billion

Kimberly Redmond  |

Image source: Interplex

US private equity firm Blackstone Inc (NYSE:  BX) is in talks to acquire Interplex Holdings, a Singapore-based technology and engineering company, in a transaction worth at least $1 billion. 

Citing confidential sources,

Reuters reported on Tuesday that Blackstone has emerged as a leading bidder and that a deal could be announced within a few weeks.

Sources said Blackstone is now hammering out the details of a transaction with Interplex’s owner, Baring Private Equity Asia (BPEA).

Blackstone is said to have no exclusivity, as other parties remain in contention, sources said.

introtext

Interplex makes components used in electric vehicles, medical and scientific equipment, autonomous driving applications and cloud computing. According to its website, the company has customers in more than two dozen locations in 13 countries. 

BPEA bought Interplex, formerly known as Amtek Engineering, in 2016 from CVC Capital Partners and Standard Chartered Private Equity, taking the company private in a $331 million deal.

None of the relevant parties commented on Tuesday’s report.

The potential deal comes two months after Blackstone announced a $3.05 billion bid for Chinese property developer Soho China. https://www.bloomberg.com/news/articles/2021-06-16/blackstone-offers-up-to-3-05-billion-for-developer-soho-china  

The transaction, which is under review by China’s antitrust regulator, is Blackstone’s biggest bet yet on the commercial real estate market in Asia’s largest economy. 

_____

Equities News

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content